Literature DB >> 21378166

G-actin participates in RNA polymerase II-dependent transcription elongation by recruiting positive transcription elongation factor b (P-TEFb).

Tianyang Qi1, Wen Tang, Ling Wang, Lei Zhai, Lijing Guo, Xianlu Zeng.   

Abstract

Actin is a key regulator of RNA polymerase (Pol) II-dependent transcription. Positive transcription elongation factor b (P-TEFb), a Cdk9/cyclin T1 heterodimer, has been reported to play a critical role in transcription elongation. However, the relationship between actin and P-TEFb is still not clear. In this study, actin was found to interact with Cdk9, a catalytic subunit of P-TEFb, in elongation complexes. Using immunofluorescence and immunoprecipitation assays, Cdk9 was found to bind to G-actin through the conserved Thr-186 in the T-loop. Overexpression and in vitro kinase assays showed that G-actin promotes P-TEFb-dependent phosphorylation of the Pol II C-terminal domain. An in vitro transcription experiment revealed that the interaction between G-actin and Cdk9 stimulated Pol II transcription elongation. ChIP and immobilized template assays indicated that actin recruited Cdk9 to a transcriptional template in vivo and in vitro. Using cytokine IL-6-inducible p21 gene expression system, we revealed that actin recruited Cdk9 to endogenous gene. Moreover, overexpression of actin and Cdk9 increased histone H3 acetylation and acetylized histone H3 binding to a transcriptional template through the interaction with histone acetyltransferase, p300. Taken together, our results suggested that actin participates in transcription elongation by recruiting Cdk9 for phosphorylation of the Pol II C-terminal domain, and the actin-Cdk9 interaction promotes chromatin remodeling.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21378166      PMCID: PMC3083233          DOI: 10.1074/jbc.M110.184374

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  54 in total

Review 1.  P-TEFb, a cyclin-dependent kinase controlling elongation by RNA polymerase II.

Authors:  D H Price
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

Review 2.  A unified theory of gene expression.

Authors:  George Orphanides; Danny Reinberg
Journal:  Cell       Date:  2002-02-22       Impact factor: 41.582

3.  NF-kappaB binds P-TEFb to stimulate transcriptional elongation by RNA polymerase II.

Authors:  M Barboric; R M Nissen; S Kanazawa; N Jabrane-Ferrat; B M Peterlin
Journal:  Mol Cell       Date:  2001-08       Impact factor: 17.970

Review 4.  Actin in the nucleus: what form and what for?

Authors:  Thoru Pederson; Ueli Aebi
Journal:  J Struct Biol       Date:  2002 Oct-Dec       Impact factor: 2.867

5.  A novel role of the actin-nucleating Arp2/3 complex in the regulation of RNA polymerase II-dependent transcription.

Authors:  Youngdong Yoo; Xiaoyang Wu; Jun-Lin Guan
Journal:  J Biol Chem       Date:  2007-01-12       Impact factor: 5.157

6.  Flavopiridol inactivates P-TEFb and blocks most RNA polymerase II transcription in vivo.

Authors:  S H Chao; D H Price
Journal:  J Biol Chem       Date:  2001-06-28       Impact factor: 5.157

7.  7SK small nuclear RNA binds to and inhibits the activity of CDK9/cyclin T complexes.

Authors:  V T Nguyen; T Kiss; A A Michels; O Bensaude
Journal:  Nature       Date:  2001-11-15       Impact factor: 49.962

8.  The 7SK small nuclear RNA inhibits the CDK9/cyclin T1 kinase to control transcription.

Authors:  Z Yang; Q Zhu; K Luo; Q Zhou
Journal:  Nature       Date:  2001-11-15       Impact factor: 49.962

9.  Physical interaction between pRb and cdk9/cyclinT2 complex.

Authors:  Cristiano Simone; Luigi Bagella; Cristiana Bellan; Antonio Giordano
Journal:  Oncogene       Date:  2002-06-13       Impact factor: 9.867

Review 10.  Nuclear actin and actin-related proteins in chromatin remodeling.

Authors:  Ivan A Olave; Samara L Reck-Peterson; Gerald R Crabtree
Journal:  Annu Rev Biochem       Date:  2001-11-09       Impact factor: 23.643

View more
  27 in total

Review 1.  Nuclear actin and myosins: life without filaments.

Authors:  Primal de Lanerolle; Leonid Serebryannyy
Journal:  Nat Cell Biol       Date:  2011-11-02       Impact factor: 28.824

Review 2.  To be or not to be assembled: progressing into nuclear actin filaments.

Authors:  Robert Grosse; Maria K Vartiainen
Journal:  Nat Rev Mol Cell Biol       Date:  2013-10-03       Impact factor: 94.444

3.  Nucleoskeletal regulation of transcription: Actin on MRTF.

Authors:  Ekaterina Sidorenko; Maria K Vartiainen
Journal:  Exp Biol Med (Maywood)       Date:  2019-05-29

Review 4.  Nuclear actin: ancient clue to evolution in eukaryotes?

Authors:  Csaba Bajusz; Péter Borkúti; Ildikó Kristó; Zoltán Kovács; Csilla Abonyi; Péter Vilmos
Journal:  Histochem Cell Biol       Date:  2018-07-17       Impact factor: 4.304

Review 5.  Nuclear actin and myosins at a glance.

Authors:  Primal de Lanerolle
Journal:  J Cell Sci       Date:  2012-11-01       Impact factor: 5.285

Review 6.  Rho, nuclear actin, and actin-binding proteins in the regulation of transcription and gene expression.

Authors:  Eeva Kaisa Rajakylä; Maria K Vartiainen
Journal:  Small GTPases       Date:  2014-03-06

7.  Nucleotide regulation of the structure and dynamics of G-actin.

Authors:  Marissa G Saunders; Jeremy Tempkin; Jonathan Weare; Aaron R Dinner; Benoît Roux; Gregory A Voth
Journal:  Biophys J       Date:  2014-04-15       Impact factor: 4.033

Review 8.  Nuclear Actin: From Discovery to Function.

Authors:  Daniel J Kelpsch; Tina L Tootle
Journal:  Anat Rec (Hoboken)       Date:  2018-11-01       Impact factor: 2.064

Review 9.  Mechanical Regulation of Transcription: Recent Advances.

Authors:  Kaustubh Wagh; Momoko Ishikawa; David A Garcia; Diana A Stavreva; Arpita Upadhyaya; Gordon L Hager
Journal:  Trends Cell Biol       Date:  2021-03-09       Impact factor: 20.808

10.  Novel role of CAP1 in regulation RNA polymerase II-mediated transcription elongation depends on its actin-depolymerization activity in nucleoplasm.

Authors:  Qian Zhang; Qin Tang; Wuyi Liu; Changpeng Hu; Xiaoyu Liu; Yali Liu; Min Zhou; Wenjing Lai; Fangfang Sheng; Haibo Yang; Jingbin Huang; Guobing Li
Journal:  Oncogene       Date:  2021-04-28       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.